抑郁症的中医养生 (TCMHPFD)
抑郁症的中医养生干预:一项随机对照试验
This study aims to evaluate the feasibility and preliminary effects of Traditional Chinese Medicine (TCM) health preservation for depression on depressive symptoms reduction and other health-related outcomes among Hong Kong Chinese adults with depression. Participants in intervention group will receive TCM health preservation course for six weeks (6 sessions, 2 hours each) and practice TCM health preservation during the 6-week follow-up period. Participants in the control group (waitlist control) will receive usual care. After the follow-up assessment, TCM health preservation courses for depression will be provided to them for compensation.
研究概览
地位
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
-
Hong Kong、香港
- School of Nursing, the Hong Kong Polytechnic University
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Hong Kong Chinese adults aged 18-years-old to 65-years-old;
- diagnosed with moderate level of depression (a score of 10~20), evaluated by the Patient Health Questionnaire-9 (PHQ-9);
- can communicate in spoken Cantonese and written Chinese;
- willing to provide written informed consent and be able to adhere to the study protocol.
Exclusion Criteria:
- being pregnant or during the lactation, or plan to get pregnant;
- new onset or change of antidepressant medication or dosage in the last 3 months;
- PHQ-9 score≥20, meaning a severe level of depression;
- with a previous or present diagnosis of psychotic disorders as screened by the Chinese version of the Structured Clinical Interview for DSM-IV;
- the score of Hong Kong Montreal Cognitive Assessment less than 22;
- significant suicidal risk as rated by the Hamilton Depression Rating Scale item on suicide (score ≥3);
- with diagnosis of illness which can interfere the individuals to participate or adhere to the modified lifestyle;
- with diagnosis of medical conditions, which are not suitable to modify diet or do physical activities recommended by physicians;
- joining in another clinical trial during the study period;
- with any major medical condition that causes depression based on the judgement of the investigator.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:traditional Chinese medicine health preservation group
The participants in the traditional Chinese medicine health preservation group will attend six traditional Chinese medicine health preservation courses (2h each per one, for 6 weeks) to learn and experience traditional Chinese medicine health preservation from a registered traditional Chinese medicine practitioner in a classroom at the School Nursing, the Hong Kong Polytechnic University. Each class will be conducted in a small group of 4 to 6 participants to enhance interaction and ensure the quality of teaching. Participants will then practice traditional Chinese medicine health preservation at home for 6 weeks. |
The traditional Chinese medicine health preservation intervention for depression was developed based on a previous systematic review and meta-analysis of Traditional Chinese medicine based integrated health interventions for depression, traditional Chinese medicine health preservation textbooks, clinical practice guidelines related to traditional Chinese medicine health preservation and traditional Chinese medicine treatment for depression. The content and structure of traditional Chinese medicine health preservation for depression was achieved among Hong Kong traditional Chinese medicine experts via a Delphi study. Usual care |
|
无干预:Waitlist control group
Participants in the waitlist control group will receive usual care during the 6-week waitlist period of intervention, and 6-week waitlist period of follow-up. After the follow-up assessment, they will be provided an equivalent traditional Chinese medicine health preservation for depression. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in the Patient Health Questionnaire (PHQ-9)
大体时间:Time Frame: Baseline, week 2, week 4, week 6, week 8, week 12
|
The PHQ-9, a self-rated questionnaire to assess the presence and severity of depressive symptoms of an individual during the last 2 weeks on a scale of 0 (not at all) to 3 (nearly every day), with a total score ranging from 0 to 27. A higher score indicates a higher severity of depression symptoms. |
Time Frame: Baseline, week 2, week 4, week 6, week 8, week 12
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in the Generalized Anxiety Disorder-7 (GAD-7)
大体时间:Time Frame: Baseline, week 2, week 4, week 6, week 8, week 12
|
The GAD-7 is a four-point Likert scale for identifying probable cases of GAD and assess the severity of symptoms of GAD for the past 2 weeks. The total score of GAD-7 varies from 0 to 21, and responses include "nearly every day," "more than half the days," "several days", and "not at all". The cutoff point of 5, 10, and 15 of GAD-7 might be interpreted as showing mild, moderate, and severe levels of anxiety. Higher scores indicate more severe GAD symptoms. |
Time Frame: Baseline, week 2, week 4, week 6, week 8, week 12
|
|
Change in the Perceived Stress Scale (PSS-10)
大体时间:Time Frame: Baseline, week 2, week 4, week 6, week 8, week 12
|
The PSS-10 is a 10-item scale that is often used for measuring perceived psychological stress. Each item is rated on a 5-point Liket scale during the past month, referring to "4" as "very often" and "0" as never. The total score changes from 0 to 40, with a higher score meaning a higher perceived psychological stress level. |
Time Frame: Baseline, week 2, week 4, week 6, week 8, week 12
|
|
Change in the Insomnia Severity Index (ISI)
大体时间:Time Frame: Baseline, week 2, week 4, week 6, week 8, week 12
|
The ISI is a seven-item self-rating scale to assess the severity of insomnia, distress, and functional impairment associated with insomnia on a 5-point Likert scale. The score of each item of ISI ranges from 0 (no problem) to 4 (very severe problem), and the total score is interpreted as below: absence of insomnia as 0 to 7, sub-threshold insomnia as 8 to14, moderate insomnia as 15 to 21, and severe insomnia as 22 to 28. |
Time Frame: Baseline, week 2, week 4, week 6, week 8, week 12
|
|
Change in the Fatigue Assessment Scale (FAS)
大体时间:Time Frame: Baseline, week 2, week 4, week 6, week 8, week 12
|
The FAS is a 10-item scale that evaluates symptoms of chronic fatigue with a five-point Likert-type scale, which ranges from 1 ("never") to 5 ("always"). A higher score means greater fatigue severity. The total score ranges from 10 to 50. A total FAS score < 22 means no fatigue, a score≥ 22 refers to fatigue. |
Time Frame: Baseline, week 2, week 4, week 6, week 8, week 12
|
|
Change in the Short-Form (six-dimension) Health Survey (SF-6D)
大体时间:Time Frame: Baseline, week 6, week 8, week 12
|
The SF-6D covers six domains using a scale of 1 to 6 to evaluate participants' general health and quality of life. Higher scores indicate better health status. |
Time Frame: Baseline, week 6, week 8, week 12
|
|
Change in the General Self-Efficacy Scale (GSE)
大体时间:Time Frame: Baseline, week 2, week 4, week 6, week 8, week 12
|
The GSE scale is a four-point Likert scale with ten items appropriate for evaluating an individual's self-efficacy. It is scored ranging from 1 point to 4 points, referring to "not at all true" to "exactly true" and the total score varied from 10 to 40. A higher score shows a more satisfactory self-efficacy. |
Time Frame: Baseline, week 2, week 4, week 6, week 8, week 12
|
|
Change in the Health-Promoting Lifestyle Profile II (HPLP II)
大体时间:Time Frame: Baseline, week 4, week 6, week 8, week 12
|
The HPLP II is a scale with 52 items and 6 domains for measuring health-promoting behavior, defined as a multidimensional pattern of self-initiated perceptions and actions that serve to maintain or increase the level of self-actualization, wellness, and fulfillment of a person. The total scores of HPLP-II varies from 52 to 208. Higher HPLP II score denotes better level of health-promoting lifestyle. |
Time Frame: Baseline, week 4, week 6, week 8, week 12
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in the Credibility/ Expectancy Questionnaire (CEQ)
大体时间:Time Frame: Baseline, week 6
|
The CEQ is a self-reported scale with 6 items and two subscales of treatment credibility and outcome expectancy to measure the participants' treatment credibility and outcome expectancy for improvement. The final scoring of the CEQ is computed by the sum of the items composing each subscale, with a higher quotation referring to higher treatment credibility and outcome expectation. The CEQ taps on participants' affective and cognitive evaluations of treatment satisfaction, credibility, and expectation. The subscale of credibility assesses beliefs about the treatment strength. The expectancy subscale assesses how participants perceive their symptoms will improve during the intervention period. |
Time Frame: Baseline, week 6
|
合作者和调查者
出版物和有用的链接
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- TCMHPFD
- No.21B2/004A (其他赠款/资助编号:the Chinese Medicine Development Fund, Hong Kong Special Administrative Region, China)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
The individual participant data will be available when the study has been published. The individual participant data will be available upon request.
IPD 共享时间框架
No time restriction for the data availability
IPD 共享访问标准
The individual participant data will be available upon request
IPD 共享支持信息类型
- 研究方案
- 树液
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.